Seres Therapeutics Competitors' Key Highlights

Key Highlights

Seres Therapeutics Competitors or Alternatives

Seres Therapeutics's top competitors include Evelo Biosciences, Second Genome and Vedanta.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Seres Therapeutics's company profile

Eric D. Shaff

President & CEO

87/100
330
$267.9M
$140.7M
1
Seres Therapeutics's Competitor - Evelo Biosciences logo

Simba Gill

President & CEO

89/100
120
$290.7M
$1.5M
2
Seres Therapeutics's Competitor - Second Genome logo

Karim Dabbagh

President & CEO

83/100
60
$68.7M
$12M
3
Seres Therapeutics's Competitor - Vedanta logo

Bernat Olle

Co-Founder & CEO

84/100
90
$308.6M
$8M
4
Seres Therapeutics's Competitor - Synlogic logo

Aoife M. Brennan

President & CEO

85/100
80
$256.9M
$2M
5
Seres Therapeutics's Competitor - Finch logo

Mark Smith

CEO

86/100
190
$312.9M
$15.3M
6
Seres Therapeutics's Competitor - Indigo logo

Ronald Hovsepian

President & CEO

84/100
1,000
$1.2B
$1B
7
Seres Therapeutics's Competitor - Kaleido logo

Daniel Menichella

President & CEO

90/100
80
$226.4M
$1.1M
8
Seres Therapeutics's Competitor - Axial logo

Stewart A. Campbell

CEO

84/100
60
$94.5M
$5.2M
9
Seres Therapeutics's Competitor - Symbiotix Biotherapies logo

Nader Yaghoubi

President & CEO

70/100
$5M
10
Seres Therapeutics's Competitor - Xeno Biosciences logo

Hasan Celiker

Founder & CEO

70/100
$1.2M
11
Seres Therapeutics's Competitor - Menarini Silicon Biosystems. logo

Giuseppe Giorgini

Chairman & CEO

66/100
119
$6.8M
$2.1M
12
Seres Therapeutics's Competitor - Pharmetheus logo

CEO

- -
- -

Evelo Biosciences is one of Seres Therapeutics's top competitors. Evelo Biosciences is a Public company that was founded in Cambridge, Massachusetts in 2014. Evelo Biosciences is in the Biotechnology field. Evelo Biosciences has 208 fewer employees vs. Seres Therapeutics.

Second Genome is perceived as one of Seres Therapeutics's biggest rivals. Second Genome was founded in 2009 in Brisbane, California. Second Genome competes in the Biotechnology industry. Second Genome generates $128.7M less revenue than Seres Therapeutics.

Vedanta is a top competitor of Seres Therapeutics. Vedanta's headquarters is in Cambridge, Massachusetts, and was founded in 2010. Vedanta competes in the Biotechnology field. Vedanta generates 5.69% of Seres Therapeutics's revenue.

Frequently Asked Questions about Seres Therapeutics

  1. Who are Seres Therapeutics's top competitors?

    Seres Therapeutics's top 3 competitors are Evelo Biosciences, Second Genome, Vedanta.
  2. Who is similar to Seres Therapeutics?

    Evelo Biosciences is the most similar to Seres Therapeutics. Second Genome and Vedanta are also similar to Seres Therapeutics.
  1. Are Seres Therapeutics and Evelo Biosciences competitors?

    Yes, Evelo Biosciences is one of Seres Therapeutics’s top competitors.